Jump to content

User:Oemmler/sandbox

From Wikipedia, the free encyclopedia

IEC 62304

[edit]

The international standard IEC 62304medical device software – software life cycle processes[1] is a standard which specifies life cycle requirements for the development of medical software and software within medical devices. It is harmonized by the European Union (EU)[2] and the United States (US),[3] and therefore can be used as a benchmark to comply with regulatory requirements from both these markets.

Implications of IEC 62304 for software

[edit]

The IEC 62304 standard calls out certain cautions on using software, particularly SOUP (software of unknown pedigree or provenance). The standard spells out a risk-based decision model on when the use of SOUP is acceptable, and defines testing requirements for SOUP to support a rationale on why such software should be used.[4]

See also

[edit]

References

[edit]
  1. ^ International Electrotechnical Commission (2006). "Medical device software – Software life cycle processes" (PDF). INTERNATIONAL IEC STANDARD 62304 First edition 2006-05. International Electrotechnical Commission. Retrieved 2 June 2012.
  2. ^ Staff (26 March 2012). "European standards Medical devices". European Commission. European Commission's Directorate General for Enterprise and Industry. Retrieved 2 June 2012.
  3. ^ Staff (20 August 2012). "Recognized Consensus Standards". FDA US Food and Drug Administration. US Department of Health & Human Services. Retrieved 26 January 2015.
  4. ^ Hall, Ken (June 1, 2010). "Developing Medical Device Software to IEC 62304". EMDT - European Medical Device Technology. Retrieved 2012-12-11.
[edit]

#62304 Category:Regulation of medical devices Category:Software development process Category:Medical software


Klinische Bewertung

[edit]

Anforderungen an die klinische Bewertung

[edit]

Für die IVD Produkte fordert die Richtlinie 98/79/EG eine Leistungsbewertung statt einer klinischen Bewertung.

Klinische Daten und klinische Evidenz

[edit]

Regulatorische Anforderungen an die klinische Bewertung

[edit]

Umsetzung der Anforderungen uns Schnittstellen der klinischen Bewertung

[edit]

Bezug zwischen Validierung und klinischer Bewertung

[edit]

Neue Europäische Gesetzgebung

[edit]

Die neuen Änderungen in der 2007/47/EC weist aus, dass alle implantierbaren und KLasse III Medizinprodukte einen Nachweis der klinischen Evidenz erbringen müssen.

Untergesetzliche Ebene

[edit]

Die MEDDEV 2.7.1 bezieht sich auf die klinische Bewertung

SOUP Validierung

[edit]

xxx

IMDRF

[edit]

Das INternational Medical Device Regulators Forum (IMDRF)

xxx